Healthcare & Pharmaceuticals
🟢 SERP-Grounded (Light Telemetry)
RxCrossroads by McKesson
Programmatic AI Search & Model Visibility Audit
Share of Model (SOM)The percentage of time frontier AI models (ChatGPT, Claude, Gemini) recommend this brand for high-intent category queries.
18.0%
-6.0% 30-Day MomentumThe rolling 30-day change in algorithmic Share of Model. Positive momentum indicates increasing AI mindshare.
🧠 Neural Valency:VulnerableThe contextual sentiment of the AI's recommendation. 'Dominant' implies strong conviction, while 'Vulnerable' implies the model heavily conditions its recommendation.
Algorithmic Threat Detection
Primary Competitor Threat
AmerisourceBergen
Competitor Displacement Rate
22.0%
Competitors are displacing RxCrossroads by McKesson in 22.0% of high-intent buyer queries.The frequency at which AI models actively suggest a competitor as a superior alternative to this brand.
Algorithmic Rationale: AmerisourceBergen's extensive pharmaceutical distribution network and integrated supply chain solutions are capturing market share and search relevance.
Missing AI Citations:High-authority domains (e.g., Reddit, G2) that models cite to justify recommending competitors, where this brand currently lacks presence.
[fda.gov][nacds.org]⚠️ Identified Vulnerability:Distribution Network
Primary Threat Identified:AmerisourceBergen
Target Persona:Pharmacy Directors
🚨 Threat Velocity:6/10An algorithmic urgency score (1-10) indicating how rapidly competitors are capturing this brand's historical AI search share.
Unlock Full Threat Report (30 Free Credits)